Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-05

FDA Approved: GUANFACINE — Original Application (A2A Integrated Pharmaceuticals)

View source ↗

Summary

FDA approved the original application for guanfacine from A2A Integrated Pharmaceuticals, enabling generic guanfacine products to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

ORIG AP for GUANFACINE (GAUNFACINE)